Sidebar Ads

Sunday, January 6, 2019

Why the Bristol-Myers Squibb Acquisition Is a Bad Deal for Celgene


Why the Bristol-Myers Squibb Acquisition Is a Bad Deal for Celgene



If this proposed acquisition was a game show, it would be called "The Price Isn't Right."

Related Posts:

0 comments:

Post a Comment

Faisal Islam: Benefits changes mean a million people will be thousands of pounds worse off

These plans are more geared towards making budgetary numbers add up than fundamental welfare reform. from BBC News https://ift.tt/KvsI9qx ...